Open AccessPolymeric nanoparticles conjugate a novel heptapeptide as an epidermal growth factor receptor-active targeting ligand for doxorubicin
Author(s) -
LuYin Lin,
Liu
Publication year - 2012
Publication title -
international journal of nanomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.245
H-Index - 128
eISSN - 1178-2013
pISSN - 1176-9114
DOI - 10.2147/ijn.s32830
Subject(s) - plga , peg ratio , peptide , nanocarriers , chemistry , conjugate , doxorubicin , biophysics , nanoparticle , drug delivery , materials science , biochemistry , nanotechnology , organic chemistry , medicine , biology , mathematics , finance , economics , surgery , chemotherapy , mathematical analysis
This study was performed to develop a functional poly(D,L-lactide-co-glycolide)-poly(ethylene glycol) (PLGA-PEG)-bearing amino-active end group for peptide conjugation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom